EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
Aim: to evaluate the efficacy and tolerability of ornithine aspartate, probiotic Bioflorum Forte and their combination with steatosis and steatohepatitis in patients with alcohol and non-alcoholic fatty liver disease. Materials and methods. An open, randomized, comparative clinical study, whic...
Saved in:
Main Authors: | L. Yu. Ilchenko (Author), L. I. Melnikova (Author), M. V. Zhuravleva (Author) |
---|---|
Format: | Book |
Published: |
SINAPS LLC,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative chemoreactomic analysis of ornithine aspartate, S-ademethionine and ursodeoxycholic acid
by: I. Yu. Torshin, et al.
Published: (2022) -
NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010) -
NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010) -
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
by: Yuezhi Zhu, et al.
Published: (2024) -
Platelets in Non-alcoholic Fatty Liver Disease
by: Andrea Dalbeni, et al.
Published: (2022)